In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they plan to reclassify cannabis as a Schedule III drug. This rescheduling will realize that cannabis has legitimate medical purposes and might help open up the doorway to investigate on other prospective therapy utilizes.